Document is current
Any future updates will be listed below
-
Authors
Lyu, Ruitu
Wu, Tong https://orcid.org/0000-0001-9968-9909
Zhu, Allen C.
West-Szymanski, Diana C.
Weng, Xiaocheng https://orcid.org/0000-0002-0605-8495
Chen, Mengjie
He, Chuan https://orcid.org/0000-0003-4319-7424
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (P01 NS097206)
- License Information
-
More Information
Article History
Received: 9 April 2021
Accepted: 22 September 2021
First Online: 10 January 2022
Competing interests
: The University of Chicago has filed a patent application on KAS-seq. C.H. is a scientific founder and a member of the scientific advisory board of Accent Therapeutics, Inc. and AccuraDX, Inc., as well as a shareholder of Epican Genetech. T.W. and D.C.W.-S. are shareholders of AccuraDX, Inc.
